Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.

Wong KSL, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Himmelmann A, Kasner SE, Knutsson M, Ladenvall P, Minematsu K, Molina CA, Wang Y, Johnston SC; SOCRATES Steering Committee and Investigators.

Stroke. 2018 Jul;49(7):1678-1685. doi: 10.1161/STROKEAHA.118.020553. Epub 2018 Jun 18.

PMID:
29915123
2.

Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.

Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY; Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators.

N Engl J Med. 2018 Jul 19;379(3):215-225. doi: 10.1056/NEJMoa1800410. Epub 2018 May 16.

PMID:
29766750
3.

Stroke risk stratification in acute dizziness presentations: A prospective imaging-based study.

Kerber KA, Meurer WJ, Brown DL, Burke JF, Hofer TP, Tsodikov A, Hoeffner EG, Fendrick AM, Adelman EE, Morgenstern LB.

Neurology. 2015 Nov 24;85(21):1869-78. doi: 10.1212/WNL.0000000000002141. Epub 2015 Oct 28.

4.

Architecture design of a generic centralized adjudication module integrated in a web-based clinical trial management system.

Zhao W, Pauls K.

Clin Trials. 2016 Apr;13(2):223-33. doi: 10.1177/1740774515611889. Epub 2015 Oct 13.

5.

Expansion of Intravenous Tissue Plasminogen Activator Eligibility Beyond National Institute of Neurological Disorders and Stroke and European Cooperative Acute Stroke Study III Criteria.

Marchidann A, Balucani C, Levine SR.

Neurol Clin. 2015 May;33(2):381-400. doi: 10.1016/j.ncl.2015.01.004. Epub 2015 Feb 28. Review.

PMID:
25907912
6.

The evaluation of distal symmetric polyneuropathy: utilisation and expenditures by community neurologists.

Callaghan BC, Kerber KA, Banerjee M, Feldman EL, Morgenstern LB, Longoria R, Rodgers A, Longwell P, Lisabeth LD.

J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):113-4. doi: 10.1136/jnnp-2014-307575. Epub 2015 Jan 20. No abstract available.

PMID:
25604430
7.

Ischemic stroke subtype and presence of sleep-disordered breathing: the BASIC sleep apnea study.

Brown DL, Mowla A, McDermott M, Morgenstern LB, Hegeman G 3rd, Smith MA, Garcia NM, Chervin RD, Lisabeth LD.

J Stroke Cerebrovasc Dis. 2015 Feb;24(2):388-93. doi: 10.1016/j.jstrokecerebrovasdis.2014.09.007. Epub 2014 Dec 10.

8.

Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathy.

Callaghan BC, Kerber KA, Lisabeth LL, Morgenstern LB, Longoria R, Rodgers A, Longwell P, Feldman EL.

JAMA Neurol. 2014 Sep;71(9):1143-9. doi: 10.1001/jamaneurol.2014.1279.

9.

Screen failure data in clinical trials: Are screening logs worth it?

Elm JJ, Palesch Y, Easton JD, Lindblad A, Barsan W, Silbergleit R, Conwit R, Dillon C, Farrant M, Battenhouse H, Perlmutter A, Johnston SC.

Clin Trials. 2014 Aug;11(4):467-472. Epub 2014 Jun 12.

10.

Preimplantation genetic diagnosis (PGD) for genetic prion disorder due to F198S mutation in the PRNP gene.

Uflacker A, Doraiswamy PM, Rechitsky S, See T, Geschwind M, Tur-Kaspa I.

JAMA Neurol. 2014 Apr;71(4):484-6. doi: 10.1001/jamaneurol.2013.5884. Review.

11.

Novel oral anticoagulants in secondary prevention of stroke.

Diener HC, Easton JD, Hankey GJ, Hart RG.

Best Pract Res Clin Haematol. 2013 Jun;26(2):131-9. doi: 10.1016/j.beha.2013.07.007. Epub 2013 Jul 30. Review.

PMID:
23953901
12.

Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design.

Johnston SC, Easton JD, Farrant M, Barsan W, Battenhouse H, Conwit R, Dillon C, Elm J, Lindblad A, Morgenstern L, Poisson SN, Palesch Y.

Int J Stroke. 2013 Aug;8(6):479-83. doi: 10.1111/ijs.12129.

13.

The impact of MRI on stroke management and outcomes: a systematic review.

Burke JF, Gelb DJ, Quint DJ, Morgenstern LB, Kerber KA.

J Eval Clin Pract. 2013 Dec;19(6):987-93. doi: 10.1111/jep.12011. Epub 2012 Nov 22. Review.

14.

Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation.

Kamel H, Easton JD, Johnston SC, Kim AS.

Neurology. 2012 Oct 2;79(14):1428-34. doi: 10.1212/WNL.0b013e31826d5fe8. Epub 2012 Sep 19.

15.

Determining stroke's rank as a cause of death using multicause mortality data.

Burke JF, Lisabeth LD, Brown DL, Reeves MJ, Morgenstern LB.

Stroke. 2012 Aug;43(8):2207-11. doi: 10.1161/STROKEAHA.112.656967. Epub 2012 Jul 19.

16.

Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials.

Khatri P, Kleindorfer DO, Yeatts SD, Saver JL, Levine SR, Lyden PD, Moomaw CJ, Palesch YY, Jauch EC, Broderick JP.

Stroke. 2010 Nov;41(11):2581-6. doi: 10.1161/STROKEAHA.110.593632. Epub 2010 Sep 2.

Supplemental Content

Loading ...
Support Center